Prophylactic Phasix™ Mesh for Incisional Hernia Prevention in IBD Surgery: A Prospective Multicenter Study (ProPhIS)
Assessing the Incidence of Incisional Hernia Rates in Inflammatory Bowel Disease Patients Undergoing Open or Minimally Invasive Abdominal Surgery With Use of Prophylactic Phasix™ Mesh Reinforcement: A Multicenter, Single-Arm, Two Strata Prospective Study.
The goal of this clinical trial is to evaluate the incidence of incisional hernia, detected by ultrasound imaging, two years after surgery in patients with Inflammatory Bowel Disease (IBD) undergoing either open or minimally invasive abdominal surgery with the use of prophylactic Phasix™ Mesh reinforcement. The study focuses on consecutive adult patients aged 18 years or older with a confirmed histological diagnosis of Crohn's disease or Ulcerative Colitis who are scheduled for elective abdominal surgery, specifically minimally invasive surgery requiring a periumbilical incision for specimen extraction or open abdominal surgery via a midline incision for patients undergoing their second or subsequent abdominal operation for IBD. The main questions it aims to answer are: what is the rate of 24-month incisional hernia as diagnosed by ultrasound imaging in the prospective study population, and how do secondary outcomes such as postoperative pain, quality of life, surgical site occurrences, and 90-day complication rates compare across these surgical strata? If there is a comparison group: Researchers will compare participants who received open surgery to those who received minimally invasive surgery to see if there are significant differences in the 24-month incisional hernia rates, complication profiles, and recovery metrics. Participants will undergo their planned abdominal surgery according to standard institutional care pathways, during which the study device-the Phasix™ Mesh-will be positioned to reinforce either the periumbilical extraction site in minimally invasive procedures or the midline incision in open surgeries using a standardized onlay technique. Following surgery, participants will be asked to complete a series of main tasks and evaluations, which include providing daily self-reported pain ratings on a Visual Analog Scale during hospitalization, attending scheduled follow-up visits at 30 days, 6 months, 12 months, and 24 months post-surgery, undergoing clinical evaluations and wound inspections with standardized photographic documentation at each visit, completing validated questionnaires including the Short-Form Health Survey-36, Ventral Hernia Pain Questionnaire, and Carolinas Comfort Scale at specified postoperative time points, and undergoing delegated ultrasound imaging of the entire length of the incision in both supine resting and dynamic states during the 12-month and 24-month follow-up visits to detect any occult or overt fascial defects or herniation.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Tipo de estudo
Tipo de estudo
Inscrição (Estimado)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
Contato de estudo
- Nome: Matteo Rottoli, MD
- Número de telefone: +39 0512144807
- E-mail: matteo.rottoli@unibo.it
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
-
Adult patients aged ≥ 18 years at the time of screening.
-
Confirmed (histologically proven) diagnosis of Crohn's disease or Ulcerative Colitis.
-
Scheduled to undergo abdominal surgery, specifically:
- Minimally invasive surgery (laparoscopic or robotic) requiring a periumbilicaln incision for specimen extraction.
- Open abdominal surgery (laparotomy) via a midline incision, for patients undergoing their second or subsequent abdominal operation for IBD.
-
Willingness and ability to provide informed consent.
-
Willingness and ability to comply with follow-up requirements, including ultrasound examinations.
Exclusion Criteria:
- Emergency surgery (e.g., for perforation with gross contamination, hemodynamic instability requiring immediate life-saving surgery without time for prophylactic mesh consideration).
- Presence of an existing incisional hernia at the planned incision site.
- Known allergy or hypersensitivity to any components of Phasix™ Mesh. In particular, known allergy to tetracycline hydrochloride or kanamycin sulfate.
- Current gross abdominal sepsis or infection that, in the surgeon's judgment, would contraindicate mesh placement.
- Life expectancy less than two years.
- Pregnant or breastfeeding women.
- Participation in another interventional trial that might confound the study results.
- Previous mesh placement at the index incision site (for open surgery patients)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: MIS with Phasix Mesh Reinforcement
Patients with Inflammatory Bowel Disease undergoing elective minimally invasive (laparoscopic or robotic) abdominal surgery who receive prophylactic Phasix Mesh reinforcement of the periumbilical specimen extraction site using a standardized technique. |
A fully resorbable monofilament scaffold (Phasix Mesh) placed during elective abdominal surgery to reinforce either the periumbilical specimen extraction site in minimally invasive surgery or the midline incision in open surgery, using a standardized onlay technique. |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
the rate of 24-month incisional hernia
Prazo: baseline
|
diagnosed by ultrasound imaging |
baseline
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
rate of 12-month incisional hernia
Prazo: baseline
|
baseline
|
|
median value of the participants-reported pain
Prazo: study visits after surgey
|
study visits after surgey
|
|
The median value of the Ventral Hernia Pain Questionnaire (VHPQ)
Prazo: after surgery
|
after surgery
|
|
The median value of the Short-Form Health Survey-36 (SF-36)
Prazo: after surgery
|
after surgery
|
|
The median value of the Carolinas Comfort Scale (CCS)
Prazo: after surgery
|
after surgery
|
|
The median difference in the 24-month VAS scores
Prazo: 24 month after surgery
|
24 month after surgery
|
|
The rate of 90-day postoperative complications classified according to the Clavien-Dindo scale
Prazo: 90 after surgery
|
90 after surgery
|
|
The rate of 90-day reoperations
Prazo: 90 after surgery
|
90 after surgery
|
|
The rate of 24-month incisional hernia between the participants who received open surgery and those who received MIS.
Prazo: 24 months after surgery
|
24 months after surgery
|
|
The median difference in the 24-month VHPQ scores
Prazo: 24 months after surgery
|
24 months after surgery
|
|
The median difference in the 24-month SF-36 scores
Prazo: 24 months after surgery
|
24 months after surgery
|
|
The median difference in the 24-month CCS scores
Prazo: 24 months after surgery
|
24 months after surgery
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Início do estudo
Conclusão Primária (Estimado)
Conclusão Primária
Conclusão do estudo (Estimado)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- ProPhIS
- CyberGrant 103751599 (Número de outro subsídio/financiamento: Becton Dickinson Holdings Pte Ltd)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .